Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A third of patients treated with Opdivo plus Yervoy experienced complete or partial tumor remission.
Tecentriq plus Avastin improved both overall survival and patient-reported outcomes.
Immunotherapy led to fewer side effects and better quality of life than standard-of-care therapy.
There are now five targeted therapies for the most common type of liver cancer.
Cabometyx is the third liver cancer drug approved in the past six months.
Rick George credits his spiritual life with seeing him through multiple health crises, including liver cancer.
Precision medicine matches patients with the treatments most likely to work for them.
Adding internal radiation or TACE did appear to help certain people, however.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.